Billionaires Holding CLVS

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 34.0M
    Shares Outstanding

  • 1.51B
    Market Cap

News & Insights

ABOUT

CLVS

Clovis Oncology Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. Clovis target its development programs for the treatment of specific subsets o...

Germany’s Economy Revs Up

NEWS

The Morning Ledger: WTO Deadline Could Hurt Firms with Supply Chains in China

READ MORE